Movatterモバイル変換

[0]ホーム
URL:

Kiaii et al., 2013 - Google Patents

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile

Kiaii et al., 2013

ViewPDF
Document ID
16424309488895938945
Author
Kiaii S
Kokhaei P
Mozaffari F
Rossmann E
Pak F
Moshfegh A
Palma M
Hansson L
Mashayekhi K
Hojjat-Farsangi M
Österborg A
Choudhury A
Mellstedt H
Publication year
Publication venue
Cancer Immunology, Immunotherapy

External Links

Snippet

T cells may have a role in sustaining the leukemic clone in chronic lymphocytic leukemia (CLL). In this study, we have examined the ability of T cells from CLL patients to support the survival of the leukemic B cells in vitro. Additionally, we compared global gene expression of …
Continue reading atpmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

PublicationPublication DateTitle
Liu et al.Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma
Kiaii et al.T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile
Verstappen et al.The transcriptome of paired major and minor salivary gland tissue in patients with primary Sjögren’s syndrome
Keller et al.The expansion of human T-bethighCD21low B cells is T cell dependent
Golinski et al.CD11c+ B cells are mainly memory cells, precursors of antibody secreting cells in healthy donors
Ilander et al.Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Henneken et al.Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus
Gourdin et al.Autocrine adenosine regulates tumor polyfunctional CD73+ CD4+ effector T cells devoid of immune checkpoints
Christopoulos et al.Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
Humblin et al.IRF8-dependent molecular complexes control the Th9 transcriptional program
Eissler et al.Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
Maher et al.Chronic fatigue syndrome is associated with diminished intracellular perforin
Fessler et al.Lymphopenia in primary Sjögren’s syndrome is associated with premature aging of naïve CD4+ T cells
Laudanski et al.Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways
Wallace et al.Direct measurement of T cell subset kinetics in vivo in elderly men and women
Nagafuchi et al.Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4+ T cells and disease activity
Burgess et al.CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro
Ramello et al.Polyfunctional KLRG-1+ CD57+ senescent CD4+ T cells infiltrate tumors and are expanded in peripheral blood from breast cancer patients
Auer et al.Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis
Pranzatelli et al.BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Gaydosik et al.Single-cell RNA sequencing unveils the clonal and transcriptional landscape of cutaneous T-cell lymphomas
Borgström et al.Three adult cases of STAT1 gain-of-function with chronic mucocutaneous candidiasis treated with JAK inhibitors
Zhang et al.The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis
Busch et al.Circulating monocytes and tumor-associated macrophages express recombined immunoglobulins in glioblastoma patients
Guo et al.A role for receptor-interacting protein kinase-1 in neutrophil extracellular trap formation in patients with systemic lupus erythematosus: a preliminary study
[8]ページ先頭
©2009-2025 Movatter.jp